Search

Search Constraints

You searched for: Author/Creator Reimer, Peter

Search Results

1. Cyclophosphamide‐based stem cell mobilization in relapsed multiple myeloma patients: A subgroup analysis from the phase III trial ReLApsE. (24th May 2017)

2. Histopathological changes resulting from selective internal radiotherapy (SIRT). Issue 5 (15th February 2018)

4. Liver resection after selective internal radiotherapy (SIRT): Proof of concept, initial survival, and safety. Issue 4 (8th August 2015)

6. Optical genome mapping reveals additional prognostic information compared to conventional cytogenetics in AML/MDS patients. Issue 12 (7th February 2022)

7. Paclitaxel-Coated Balloon vs Uncoated Balloon Angioplasty for Treatment of In-Stent Restenosis in the Superficial Femoral and Popliteal Arteries: The COPA CABANA Trial. (April 2020)

8. Phase I/II study on cytarabine and idarubicin combined with escalating doses of clofarabine in newly diagnosed patients with acute myeloid leukaemia and high risk for induction failure (AMLSG 17‐10 CIARA trial). (30th October 2018)

9. Preinfection laboratory parameters may predict COVID‐19 severity in tumor patients. (13th June 2021)

10. Rationale and design of the German-Speaking Myeloma Multicenter Group (GMMG) trial ReLApsE: a randomized, open, multicenter phase III trial of lenalidomide/dexamethasone versus lenalidomide/dexamethasone plus subsequent autologous stem cell transplantation and lenalidomide maintenance in patients with relapsed multiple myeloma. Issue 1 (December 2016)